Experience

Natural health product licensed in Canada

Licence holder

Awareness Corporation Canada

NPN or DIN-HM

80072085

Status

Active licence

Licence date

17 August 2016

Revision date

1 September 2022

Form

Capsule

Route of administration

Orale

Application type

Non traditionnelle

If this product were sold in France

• Conditions légales

  Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

• Conditions légales

  Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.

  arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Non-medicinal ingredients

Dioxyde de silicium, Cellulose microcristalline, Hypromellose

Recommended doses in Canada

Uses authorised in Canada

Senna is traditionally used in Herbal Medicine as a stimulant laxative. Short-term relief of occasional constipation. Used in Herbal Medicine to promote bowel movement. Stimulant laxative to help support cleansing of the colon by providing short-term relief of occasional constipation and/or promoting bowel movement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

• Effets indésirables connus

  Hypersensitivity is known to occur, in which case, discontinue use. Hypersensitivity, such as allergy, has been known to occur following inhaled and/or ingested psyllium; in which case, discontinue use. May cause temporary gas and/or bloating.

• Contre-indications

  DO NOT USE If you are pregnant or breastfeeding; experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or failure to defaecate following the use of another laxative product; or allergic to anethole or plants of the Apiaceae/Carrot family. DO NOT USE If you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes; diabetes mellitus in which blood sugar is difficult to regulate; or have difficulty swallowing.

• Précautions et mises en garde

  Consult a health care practitioner If symptoms persist or worsen; or if laxative effect does not occur within seven days. Consult a health care practitioner immediately if you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product. Reduce dose or discontinue use if you experience abdominal pain, cramps, spasms and/or diarrhoea. Consult a health practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance; or medications which inhibit peristaltic movement (e.g. opioids, loperamide). Consult a health practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications; or have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis).

Source

Official Health Canada record, licence 80072085

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 1 September 2022 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.